These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37587599)

  • 1. 3-Year Outcomes From the Amplatzer Amulet Left Atrial Appendage Occluder Randomized Controlled Trial (Amulet IDE).
    Lakkireddy D; Thaler D; Ellis CR; Swarup V; Gambhir A; Hermiller J; Nielsen-Kudsk JE; Worthley S; Nair D; Schmidt B; Horton R; Gupta N; Anderson JA; Gage R; Alkhouli M; Windecker S
    JACC Cardiovasc Interv; 2023 Aug; 16(15):1902-1913. PubMed ID: 37587599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial.
    Lakkireddy D; Thaler D; Ellis CR; Swarup V; Sondergaard L; Carroll J; Gold MR; Hermiller J; Diener HC; Schmidt B; MacDonald L; Mansour M; Maini B; O'Brien L; Windecker S
    Circulation; 2021 Nov; 144(19):1543-1552. PubMed ID: 34459659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of Amulet Left Atrial Appendage Occluder and Watchman Device for Left Atrial Appendage Closure in Patients With Atrial Fibrillation.
    Sawaya F; Abi-Saleh B; Hoteit A; Jdaidany J; Moumneh MB; Harbieh B; Khoury M; Aramouni S; Abdulhai F; Refaat M
    Cureus; 2024 Mar; 16(3):e55531. PubMed ID: 38576630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale and design for AMPLATZER Amulet Left Atrial Appendage Occluder IDE randomized controlled trial (Amulet IDE Trial).
    Lakkireddy D; Windecker S; Thaler D; Søndergaard L; Carroll J; Gold MR; Guo H; Brunner KJ; Hermiller JB; Diener HC; Schmidt B; MacDonald L; Mansour M; Maini B; Levine J
    Am Heart J; 2019 May; 211():45-53. PubMed ID: 30831333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peridevice Leak After Transcatheter Left Atrial Appendage Occlusion: An Analysis of the Amulet IDE Trial.
    Price MJ; Ellis CR; Nielsen-Kudsk JE; Thaler D; Gupta N; Koulogiannis K; Anderson JA; Gage R; Lakkireddy D
    JACC Cardiovasc Interv; 2022 Nov; 15(21):2127-2138. PubMed ID: 36357016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of percutaneous Watchman 2.5 device versus Amplatzer Amulet for left atrial appendage closure in patients with non-valvular atrial fibrillation: A systematic review and study-level meta-analysis.
    Yasmin F; Ali E; Moeed A; Zaidi F; Umar M; Virwani V
    PLoS One; 2024; 19(2):e0295804. PubMed ID: 38354181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms, predictors, and evolution of severe peri-device leaks with two different left atrial appendage occluders.
    Lakkireddy D; Nielsen-Kudsk JE; Windecker S; Thaler D; Price MJ; Gambhir A; Gupta N; Koulogiannis K; Marcoff L; Mediratta A; Anderson JA; Gage R; Ellis CR
    Europace; 2023 Aug; 25(9):. PubMed ID: 37584233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex Differences in Safety and Effectiveness of LAAO: Insights From the Amulet IDE Trial.
    Alkhouli M; Russo AM; Thaler D; Windecker S; Anderson JA; Gage R; Lakkireddy D
    JACC Cardiovasc Interv; 2022 Nov; 15(21):2143-2155. PubMed ID: 36357018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical efficacy and safety comparison of Watchman device versus ACP/Amulet device for percutaneous left atrial appendage closure in patients with nonvalvular atrial fibrillation: A study-level meta-analysis of clinical trials.
    Bing S; Chen RR
    Clin Cardiol; 2023 Feb; 46(2):117-125. PubMed ID: 36448417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One year outcome and analysis of peri-device leak of left atrial appendage occlusion devices.
    Mansour MJ; Harnay E; Al Ayouby A; Mansourati V; Jobic Y; Gilard M; Le Ven F; Mansourati J
    J Interv Card Electrophysiol; 2022 Jun; 64(1):27-34. PubMed ID: 34002319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short term outcome after left atrial appendage occlusion with the AMPLATZER Amulet and WATCHMAN device: results from the ORIGINAL registry (saxOnian RegIstry analyzinG and followINg left atrial Appendage cLosure).
    Kretzler L; Mues C; Wunderlich C; Langbein A; Spitzer SG; Gerk U; Schellong S; Ketteler T; Neuser H; Schwefer M; Strasser R; Ibrahim K; Schoen S; Christoph M
    BMC Cardiovasc Disord; 2022 Jun; 22(1):271. PubMed ID: 35710343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of the roll-in cohort of the Amulet IDE trial of left atrial appendage occlusion.
    Lakkireddy D; Thaler D; Ellis CR; Swarup V; Sondergaard L; Carroll J; Gold MR; Hermiller J; Diener HC; Schmidt B; MacDonald L; Mansour M; Maini B; Anderson JA; Gage R; Windecker S;
    Heart Rhythm O2; 2022 Oct; 3(5):493-500. PubMed ID: 36340489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of the SWISS-APERO Randomized Clinical Trial.
    Galea R; De Marco F; Meneveau N; Aminian A; Anselme F; Gräni C; Huber AT; Teiger E; Iriart X; Babongo Bosombo F; Heg D; Franzone A; Vranckx P; Fischer U; Pedrazzini G; Bedogni F; Räber L; Valgimigli M
    Circulation; 2022 Mar; 145(10):724-738. PubMed ID: 34747186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of the Amplatzer Amulet and Watchman 2.5 for left atrial appendage occlusion: A systematic review and meta-analysis.
    Zhu MZ; Song H; Song GM; Bai X
    Pacing Clin Electrophysiol; 2022 Oct; 45(10):1237-1247. PubMed ID: 35933600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials.
    Reddy VY; Doshi SK; Kar S; Gibson DN; Price MJ; Huber K; Horton RP; Buchbinder M; Neuzil P; Gordon NT; Holmes DR;
    J Am Coll Cardiol; 2017 Dec; 70(24):2964-2975. PubMed ID: 29103847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left atrial appendage sealing performance of the Amplatzer Amulet and Watchman FLX device.
    Korsholm K; Kramer A; Andersen A; Saw J; Nørgaard BL; Jensen JM; Nielsen-Kudsk JE
    J Interv Card Electrophysiol; 2023 Mar; 66(2):391-401. PubMed ID: 35951214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between Amplatzer and Watchman Left Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis.
    Qiao J; Zhang B; Wang J; Pan L; Cheng T; Wang Y; Xiong E
    Cardiology; 2022; 147(3):290-297. PubMed ID: 35468598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First Experience With Amulet in the United States: Early Insights From EMERGE LAA Postapproval Study.
    Alkhouli M; Freeman JV; Ellis CR; Shah AP; Gada H; Coylewright M; Lo M; Makkar A; Agarwal H; Lakkireddy D
    JACC Cardiovasc Interv; 2024 Jan; ():. PubMed ID: 38310499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence, Predictors, and Clinical Outcomes of Device-Related Thrombus in the Amulet IDE Trial.
    Schmidt B; Nielsen-Kudsk JE; Ellis CR; Thaler D; Sabir SA; Gambhir A; Landmesser U; Shah N; Gray W; Swarup V; Lim DS; Koulogiannis K; Anderson JA; Gage R; Lakkireddy D
    JACC Clin Electrophysiol; 2023 Jan; 9(1):96-107. PubMed ID: 36697204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between Amulet and Watchman left atrial appendage closure devices: A real-world, single center experience.
    Saad M; Risha O; Sano M; Fink T; Heeger CH; Vogler J; Sciacca V; Eitel C; Stiermaier T; Joost A; Keelani A; Fuernau G; Meyer-Saraei R; Kuck KH; Eitel I; Richard Tilz R
    Int J Cardiol Heart Vasc; 2021 Dec; 37():100893. PubMed ID: 34712772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.